Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-31

Clinical Trial Update: A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the analgesic efficacy of ASP7962 in knee osteoarthritis has completed. The study also included patients with chronic lower back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASP7962

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Osteoarthritis of the Knee, Chronic Lower Back Pain | Phase 2 | Status: COMPLETED